CRAI Stock Analysis: CRA International | NASDAQ
Consulting Services | NASDAQ, USA | Market Cap: 1.083m USD | 12M Return: -9.5% | US12618T1051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 20.4M
EPS Trend: 91.4%
Qual. Beats: 0
Rev. Trend: 99.8%
Qual. Beats: 5
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CRA International, Inc. (NASDAQ: CRAI) is a global consulting firm specializing in economic, financial, and management advisory services, classified within the Industrials sector under the Research & Consulting Services sub-industry. The company supports clients facing litigation and regulatory proceedings by providing research, expert testimony, and analysis across finance, accounting, economics, insurance, and forensic investigations. It also delivers management consulting work on corporate strategy, performance improvement, ESG and sustainability, auction and bidding design, and intellectual property valuation, operating on a professional services model that monetizes expert time and analytical engagements rather than physical products.
Founded in 1965 and headquartered in Boston, Massachusetts, CRA has been publicly listed since its 1998 IPO and serves a diverse client base spanning industries such as energy, healthcare, life sciences, financial services, technology, transportation, communications and media, and emerging areas including blockchain and cryptocurrency. Its revenue is generated primarily through engagements with law firms, corporate clients, and government entities requiring specialized economic and financial expertise.
- Antitrust litigation and regulatory complexity boost consulting demand
- Life sciences and energy transition engagements expand revenue mix
- Share repurchases and dividends supplement modest organic growth
| Net Income: 49.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA -7.65 > 1.0 |
| NWC/Revenue: 2.38% < 20% (prev -3.40%; Δ 5.78% < -1%) |
| CFO/TA -0.03 > 3% & CFO -21.7m > Net Income 49.3m |
| Net Debt (260.6m) to EBITDA (247.6m): 1.05 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (6.41m) vs 12m ago -5.12% < -2% |
| Gross Margin: 26.80% > 18% (prev 32.02%; Δ -5.22% > 0.5%) |
| Asset Turnover: 124.9% > 50% (prev 117.5%; Δ 7.45% > 0%) |
| Interest Coverage Ratio: 15.25 > 6 (EBIT TTM 77.4m / Interest Expense TTM 5.08m) |
| A: 0.03 (Total Current Assets 349.0m - Total Current Liabilities 330.0m) / Total Assets 665.3m |
| B: 0.29 (Retained Earnings 192.2m / Total Assets 665.3m) |
| C: 0.12 (EBIT TTM 77.4m / Avg Total Assets 636.0m) |
| D: 0.38 (Book Value of Equity 182.7m / Total Liabilities 482.4m) |
| Altman-Z'' = 2.34 = BBB |
| DSRI: 0.94 (Receivables 265.6m/253.0m, Revenue 794.6m/712.9m) |
| GMI: 1.19 (GM 32.02% / 26.80%) |
| AQI: 1.02 (AQ_t 0.32 / AQ_t-1 0.31) |
| SGI: 1.11 (Revenue 794.6m / 712.9m) |
| TATA: 0.11 (NI 49.3m - CFO -21.7m) / TA 665.3m) |
| Beneish M = -2.79 (Cap -4..+1) = A |
As of August 30, 2026, the stock is trading at USD 174.99 with a total of 92,956 shares traded. Over the past week, the price has changed by -0.76%, over one month by -2.46%, over three months by +18.34% and over the past year by -9.48%.
Current recommended Stop Loss: 161.50 (which is 7.7% or 2.1 ATR below the current price).
CRA International has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold CRAI.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 250.5 | 43.2% |
P/E Trailing = 22.6675
P/E Forward = 20.3252
P/S = 1.3626
P/B = 5.8824
P/EG = 1.2703
Revenue TTM = 794.6m USD
EBIT TTM = 77.4m USD
EBITDA TTM = 247.6m USD
Long Term Debt = 143.0m USD (estimated: total debt 194.2m - short term 51.2m)
Short Term Debt = 51.2m USD (from shortTermDebt, last quarter)
Debt = 278.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 84.7m
Net Debt = 260.6m USD (calculated: Debt 278.8m - CCE 18.2m)
Enterprise Value = 1.34b USD (1.08b + Debt 278.8m - CCE 18.2m)
Interest Coverage Ratio = 15.25 (Ebit TTM 77.4m / Interest Expense TTM 5.08m)
EV/FCF = -48.42x (Enterprise Value 1.34b / FCF TTM -27.7m)
FCF Yield = -2.07% (FCF TTM -27.7m / Enterprise Value 1.34b)
FCF Margin = -3.49% (FCF TTM -27.7m / Revenue TTM 794.6m)
Net Margin = 6.20% (Net Income TTM 49.3m / Revenue TTM 794.6m)
Gross Margin = 26.80% ((Revenue TTM 794.6m - Cost of Revenue TTM 581.7m) / Revenue TTM)
Gross Margin QoQ = 29.45% (prev 26.15%)
Tobins Q-Ratio = 2.02 (Enterprise Value 1.34b / Total Assets 665.3m)
Interest Expense / Debt = 1.82% (Interest Expense 5.08m / Debt 278.8m)
Taxrate = 31.84% (23.0m / 72.3m)
NOPAT = 52.8m (EBIT 77.4m * (1 - 31.84%))
Current Ratio = 1.06 (Total Current Assets 349.0m / Total Current Liabilities 330.0m)
Debt / Equity = 1.53 (Debt 278.8m / totalStockholderEquity, last quarter 182.7m)
Debt / EBITDA = 1.05 (Net Debt 260.6m / EBITDA 247.6m)
Debt / FCF = -9.39 (negative FCF - burning cash) (Net Debt 260.6m / FCF TTM -27.7m)
Total Stockholder Equity = 199.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.75% (Net Income 49.3m / Total Assets 665.3m)
RoE = 24.76% (Net Income TTM 49.3m / Total Stockholder Equity 199.1m)
RoCE = 22.63% (EBIT 77.4m / Capital Employed (Equity 199.1m + L.T.Debt 143.0m))
RoIC = 14.33% (NOPAT 52.8m / Invested Capital 368.2m)
WACC = 4.89% (E(1.08b)/V(1.36b) * Re(5.83%) + D(278.8m)/V(1.36b) * Rd(1.82%) * (1-Tc(0.32)))
Discount Rate = 5.83% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.00 | Cagr: -3.92%
[DCF] Fair Price = unknown (Cash Flow -27.7m)
EPS Correlation: 91.38 | EPS CAGR: 18.86% | SUE: 0.25 | # QB: 0
Revenue Correlation: 99.83 | Revenue CAGR: 9.84% | SUE: 4.0 | # QB: 5
EPS current Quarter (2026-09-30): EPS=2.07 | Chg30d=-5.47% | Revisions=-25% | Analysts=3
EPS current Year (2026-12-31): EPS=8.47 | Chg30d=-1.47% | Revisions=-25% | GrowthEPS=+2.9% | GrowthRev=+8.3%
EPS next Year (2027-12-31): EPS=9.56 | Chg30d=-0.73% | Revisions=+25% | GrowthEPS=+12.9% | GrowthRev=+4.0%
[Analyst] Revisions Ratio: -17% (up=1, down=2)